newsfilter
← Latest News
GlobeNewswire·

Lyell Immunopharma Announces Participation in September Investor Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (NASDAQ:LYEL), Lyell Immunopharma, Inc. (NASDAQ:LYEL), a late-stage clinical company advancing next-generation CAR T-cell